GlassScriptPhysician profile
Ryan Floyd Mckenna
NPI 1801152079
$8,415.78
in general payments reported to CMS, 2019-2025
16 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,233 · 2020: $1,062 · 2021: $1,109 · 2022: $1,027 · 2023: $16.16 · 2024: $946 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,204.91 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $2,096.51 | 2019-2020 | |
| Medtronic, INC. | $1,989.69 | 2019-2024 | Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $1,445.62 | 2019-2020 | |
| Nevro Corp. | $193.41 | 2019-2021 | |
| Vertos Medical, INC. | $92.16 | 2019-2022 | |
| Abbvie INC. | $79.52 | 2021-2024 | |
| Stryker Corporation | $73.09 | 2025 | Optablate, Mild Device Kit |
| Collegium Pharmaceutical, INC. | $72.48 | 2019-2024 | Xtampza |
| Vertiflex, INC. | $51.65 | 2019 | |
| Amgen INC. | $38.89 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.06 | 2022 | |
| Horizon Therapeutics Plc | $17.43 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.07 | 2020 | |
| Allergan, INC. | $14.26 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.